These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38327729)

  • 1. The Effects of Pharmacist-Led Medication Therapy Management on Medication Adherence and Use of Non-Steroidal Anti-Inflammatory Drug in Patients with Pre-End Stage Renal Disease.
    Wang T; Kang HC; Chen CC; Lai TS; Huang CF; Wu CC
    Patient Prefer Adherence; 2024; 18():267-274. PubMed ID: 38327729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pharmacist-led medication therapy management in the multidisciplinary care of acute kidney injury survivors.
    Wang T; Kang HC; Wu CC; Wu TL; Huang CF; Wu VC
    Kidney Res Clin Pract; 2024 Jul; 43(4):548-558. PubMed ID: 38934027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of pharmacist intervention model for chronic kidney disease patients; a prospective comparative study.
    Khokhar A; Khan YH; Mallhi TH; Khan HM; Alotaibi NH; Alzarea AI; Bokharee N
    Int J Clin Pharm; 2020 Apr; 42(2):625-634. PubMed ID: 32026352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
    Perera PN; Guy MC; Sweaney AM; Boesen KP
    J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic.
    Shahrami B; Sefidani Forough A; Najmeddin F; Hadidi E; Toomaj S; Javadi MR; Gholami K; Sadeghi K
    J Clin Pharm Ther; 2022 Jul; 47(7):964-972. PubMed ID: 35218217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist-Led Collaborative Medication Management for the Elderly with Chronic Kidney Disease and Polypharmacy.
    Kim AJ; Lee H; Shin EJ; Cho EJ; Cho YS; Lee H; Lee JY
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33924094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist impact on medication dosing and billable coding accuracy in outpatients with chronic kidney disease.
    Cypes IN; Prohaska ES; Melton BL
    J Am Pharm Assoc (2003); 2021; 61(2):e153-e158. PubMed ID: 33160871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.
    Lalonde L; Quintana-Bárcena P; Lord A; Bell R; Clément V; Daigneault AM; Legris MÈ; Letendre S; Mouchbahani M; Jouini G; Azar J; Martin É; Berbiche D; Beaulieu S; Beaunoyer S; Bertin É; Bouvrette M; Charbonneau-Séguin N; Desrochers JF; Desforges K; Dumoulin-Charette A; Dupuis S; El Bouchikhi M; Forget R; Guay M; Lemieux JP; Morin-Bélanger C; Noël I; Ricard S; Sauvé P; Ste-Marie Paradis F
    Am J Kidney Dis; 2017 Sep; 70(3):386-396. PubMed ID: 28663062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Team-Based Medicine: Incorporating a Clinical Pharmacist into Pain and Opioid Practice Management.
    Boren LL; Locke AM; Friedman AS; Blackmore CC; Woolf R
    PM R; 2019 Nov; 11(11):1170-1177. PubMed ID: 30729723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
    Altavela JL; Jones MK; Ritter M
    J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective evaluation of medication appropriateness and clinical pharmacist drug therapy recommendations for home-based primary care veterans.
    Davis RG; Hepfinger CA; Sauer KA; Wilhardt MS
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):40-7. PubMed ID: 17608246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist-led medication therapy management of diabetes club patients at a primary healthcare clinic in Cape Town, South Africa: A retrospective and prospective audit.
    Sonday F; Bheekie A; Van Huyssteen M
    S Afr Med J; 2022 May; 112(6):437-445. PubMed ID: 36217874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home medication management review in outpatients with chronic diseases in Jordan: a randomized control trial.
    Basheti IA; Al-Qudah RA; Obeidat NM; Bulatova NR
    Int J Clin Pharm; 2016 Apr; 38(2):404-13. PubMed ID: 26960406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist-driven renal medication dosing intervention in a primary care patient-centered medical home.
    Barnes KD; Tayal NH; Lehman AM; Beatty SJ
    Pharmacotherapy; 2014 Dec; 34(12):1330-5. PubMed ID: 25346347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Care Providers' Acceptance of Pharmacists' Recommendations to Support Optimal Medication Management for Patients with Diabetic Kidney Disease.
    Zullig LL; Jazowski SA; Davenport CA; Diamantidis CJ; Oakes MM; Patel S; Moaddeb J; Bosworth HB
    J Gen Intern Med; 2020 Jan; 35(1):63-69. PubMed ID: 31659655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
    Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M
    J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists.
    Donovan JL; Schroeder WS; Tran MT; Foster K; Forrest A; Lee TB; Gandhi PJ
    J Manag Care Pharm; 2007 Sep; 13(7):598-606. PubMed ID: 17874866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pharmacist participation in chronic kidney disease (CKD) network and CKD manual distribution on drug-related kidney injury.
    Yamamoto T; Nakayama I; Kawakatsu Y; Yamamoto T; Ishigami N; Watanuki K; Okabe T; Yokoyama H
    Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):887-896. PubMed ID: 31038268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.